When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.

Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation.

The convening power of clinical ethics committees stems from their reputation for fairness and procedural legitimacy in addressing and resolving ethically complex cases.

Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients.

The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient.

Eliminating cervical cancer inequality means transmen need regular, unimpeded access to regular Pap screening.

Author Ryan Sallans discusses his experience accessing health care and suggests how to take good gynecological care of transmen.

Because research on the efficacy of approaches to addiction recovery is inconclusive, clinicians should recommend several, including 12-step approaches.